NCT05761171 2026-03-31A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory LeukemiaChildren's Oncology GroupPhase 2 Active not recruiting78 enrolled
NCT01574274 2026-02-05SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic LymphomaDana-Farber Cancer InstitutePhase 2 Active not recruiting240 enrolled 14 charts